Global Carcinoembryonic Antigen Market Key Growth Drivers and Global Industry Foresight 2019 - 2023
Global Carcinoembryonic Antigen Market Research Report: Information by Application (Colorectal Cancer, Pancreatic Cancer, Breast Cancer, Lung Cancer, and Others), End User (Hospitals and Clinics, Diagnostic Centers, and Others), and Region (the Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Forecast till 2025
Market Highlights
Carcinoembryogenic antigen (CEA) is a group
of glycoproteins which are produced during the fetal developmental stages by
gastrointestinal tissues. CEA is responsible for cell adhesion. Healthy adults
do not have CEA concentrations. However, smoking and certain medical conditions
such as colorectal cancer, breast cancer etc. can mark the presence of CEA in
the body. Thus, CEA based diagnostic assays are used for the detection of such
cancers and to check the treatment efficiency during the therapeutic period by
a physician.
Avail
a Free Sample@ https://www.marketresearchfuture.com/sample_request/772
In 2017, studies of the
NCBI suggested that the global burden of colorectal cancer will increase by
60%, leading to 2.2 million new cancer cases and 1.1 million deaths by 2030.
This will increase the colorectal cancer diagnostic demands, thereby propelling
the market growth.
Increasing prevalence of
cancer, rising healthcare expenditures, and developing diagnostic technologies
will boost the global market during the forecast period. However, risk of
infection and hematoma, lack of awareness and medical services in the
developing countries will restrain the market growth during the assessment
period.
Market Players
Some of key players
profiled in the report are Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics
Incorporated., Correlogic Systems, Inc, Genway Biotech, Inc., Abbott.,
RayBiotech, Inc., Abcam plc., Biocare Medical, LLC, and Biocare Medical, LLC.
Regional Analysis
The Americas account for the
largest share in the carcinoembryogenic antigen market. The Americas mainly
include countries like the U.S. and Canada. Increasing prevalence of cancer and
high healthcare expenditures within the region will boost the market growth
over the assessment period.
Europe is the second
highest revenue generating region in the global carcinoembryogenic antigen
market. Increasing prevalence of cancer, fast adoption of new technologies and
presence of developed countries like Germany and U.K within the region will
boost the market growth during the forecasted period.
On account of the
developing medical infrastructure, rising healthcare expenditure, and
increasing government initiatives, Asia Pacific region is expected to grow the
fastest.
The Middle East &
Africa is expected to grow slower than the global average. The Middle Eastern
countries, for instance, UAE and Saudi Arabia dominates the market due to high
income and the government support to improve public health.
Taste the market data and
market information presented through more than 50 market data tables and
figures spread over 80 pages of the project report. Avail the in-depth table of
content (TOC) & market synopsis on “Global Carcinoembryogenic Antigen
Market” Research Report – Forecast till 2023.
Segmentation
The global carcinoembryonic
antigen market has been segmented on the basis of application, sampling, and
end user.
Based on application, the
market has been segmented into colorectal, pancreatic, breast, lung cancer, and
others.
Based on sampling, the
market has been segmented into antecubital, peritoneal, pleural, serebrospinal,
and others.
Based on the end users, the
market has been segmented into hospitals, diagnostic centers, research centers,
and others.
Access Report Details @ https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market-772
The report for Global market by Market
Research Future comprises of extensive primary research along with the detailed
analysis of qualitative as well as quantitative aspects by various industry
experts, key opinion leaders to gain a deeper insight of the market and
industry performance. The report gives a clear picture of the current market
scenario which includes past and estimated future market size with respect to
value and volume, technological advancement, macro economical and governing
factors in the market. The report provides detail information about and
strategies used by top key players in the industry. The report also gives a
broad study of the different market segments and regions.
Intended Audience
- Biotechnology companies
- Pharmaceutical companies
- Hospitals and clinics
- Diagnostic centers
- Academic institutes
- Government organizations
TOC:
1.
Report Prologue
2. Market
Introduction
2.1
Definition
2.2 Scope of the Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
3. Research
Methodology
3.1 Introduction
3.2 Primary
Research
3.3 Secondary research
3.4 Market Size
Estimation
TOC…Continued
Ask
Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/772
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by Components, Application, Logistics and market
players for global, regional, and country level market segments, enable our
clients to see more, know more, and do more, which help to answer all their
most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone: +1 646 845 9312
Comments
Post a Comment